Newsletter

115180 - Qurient Co., Ltd.

115180 Summary
Biopharma
Stock Price & Overview
₩23,050 +3,400 (+17.30%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩23,050  ≈ US$16  ·  Market cap ₩0.9tn (≈ $618m)
Home › 115180 › Filings

5% Ownership Report — Large Holdings

DART
Qurient Co., Ltd.
Filed Aug 5, 2026 KST · Ownership · receipt 20260805000316

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 주식등의대량보유상황보고서(일반)

115180

Price
₩23,050
Change
+17.30%
Market cap
₩0.9tn
Prev. close
₩19,650
115180 SummaryCompare to Peers

More 115180 filings

Investor Relations Event

09/04/26

Securities registration statement (equity securities)

09/04/26

Material event report (paid-in capital increase)

09/04/26

Material matter affecting investment judgment (clinical trial plan approval)

08/18/26

Half-Year Report

08/14/26

5% Ownership Report — Large Holdings

08/04/26